CUAMC
TCRT icon

China Universal Asset Management Company’s Alaunos Therapeutics TCRT Stock Holding History

China Universal Asset Management Company’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-41
Closed -$815 – 481
2023
Q3 		$815 Buy
41
+20
+95% +$862 ﹤0.01% 443
2023
Q2 		$1.61K Sell
21
-1
-5% -$81 ﹤0.01% 437
2023
Q1 		$2.05K Buy
22
+6
+38% +$571 ﹤0.01% 431
2022
Q4 		$1.58K Buy
16
+3
+23% +$435 ﹤0.01% 384
2022
Q3 		$3K Buy
+13
New +$3.78K ﹤0.01% 337

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

China Universal Asset Management Company's TCRT Position: Q4 2023 in Review

China Universal Asset Management Company sold out of Alaunos Therapeutics (TCRT) in Q4 2023, closing a stake of 41 shares — an estimated $815 sold.

China Universal Asset Management Company first reported a position in TCRT in Q3 2022 and held it in 5 quarters. The position peaked at $3K in Q3 2022. 82 funds tracked by Wall St. Rank hold TCRT as of Q4 2023.

  • China Universal Asset Management Company reported no remaining Alaunos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • China Universal Asset Management Company sold 41 Alaunos Therapeutics shares in Q4 2023, an estimated $815.
  • China Universal Asset Management Company first reported a position in Alaunos Therapeutics in Q3 2022 and held it in 5 quarters.
  • China Universal Asset Management Company's Alaunos Therapeutics position peaked at $3K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2023.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.